Because of the remarkably improved image quality and wearability of modern headmounted displays, a monitoring system using a head-mounted display rather than a fixed-site monitor for sonographic scanning has the potential to improve the diagnostic performance and lessen the examiner's physical burden during a sonographic examination. In a preclinical setting, 2 head-mounted displays, the HMZ-T2 (Sony Corporation, Tokyo, Japan) and the Wrap1200 (Vuzix Corporation, Rochester, NY), were found to be applicable to sonography. In a clinical setting, the feasibility of the HMZ-T2 was shown by its good image quality and acceptable wearability. This modern device is appropriate for clinical use in sonography.
utility of this modern head-mounted display system led us to use the head-mounted display for clinical sonographic scanning. Here we evaluate the feasibility of modern headmounted displays for sonography scanning and describe the clinical application of this device.
Materials and Methods
This study was conducted under the approval of our university's Ethics Committee. First, we analyzed the feasibility of modern head-mounted displays for sonographic examinations in a preclinical setting. We evaluated the applicability of the 2 latest commercially available headmounted displays: the HMZ-T2 (Sony Corporation, Tokyo, Japan), a goggle-type device ( Figure 1 ) with a resolution of 1280 × 720 pixels and a weight of 330 g; and the Wrap1200 (Vuzix Corporation, Rochester, NY), an eyeglass-type device ( Figure 2 ) with a resolution of 852 x 480 pixels and a weight of 108 g. Next, we conducted a clinical evaluation of this system. All scanning was performed with a Noblus ultrasound system (Hitachi Aloka Medical, Ltd, Tokyo, Japan) and a convex 1-5-MHz transducer.
In the preclinical study, 18 sonographers who were familiar with urogenital tract scanning evaluated the feasibility of the head-mounted displays during scanning of a healthy male volunteer. The examiners were randomly divided into 2 groups. To minimize the potential influence of the order in which the head-mounted displays were evaluated, half of the examiners evaluated the HMZ-T2 first and the Wrap1200 second, whereas the other half evaluated the Wrap1200 first and the HMZ-T2 second. On the basis of the results of the preclinical analysis, we determined which of these 2 head-mounted displays would be used in the succeeding clinical study.
In the clinical study, 5 urologists who had more than 5 years of urologic clinical experience and were familiar with urogenital sonography participated. They used the head-mounted display during sonographic examinations in our outpatient clinic for 1 week in July 2013. After a complete description of the sonographic examination using the head-mounted display, informed consent was obtained from all participating patients. The sonographic examinations included an analysis of the bilateral kidneys, the urinary bladder, and the prostate (if male) over about 5 minutes.
In both the preclinical and clinical studies, the examiners completed a questionnaire after the sonographic examinations (Figure 3) , which evaluated the following parameters: (1) image quality of the head-mounted display compared to that of the ultrasound machine-mounted monitor; (2) diagnostic performance with the head- mounted display compared to the ultrasound machinemounted monitor; (3) wearability of the head-mounted display; (4) degree of physical fatigue; (5) degree of visual fatigue; (6) presence of motion sickness or dizziness; and (7) any positive or negative points of the head-mounted display noted by the examiner. Questions 1 through 5 were 5-level evaluation questions; question 6 was a yes-or-no question; and question 7 was a free question. The results of the questionnaires were then analyzed.
Associations were evaluated by 1-way analysis of variance using JMP version 7.0.2 software (SAS Institute Inc, Cary, NC). P < .05 was considered statistically significant.
Results

Preclinical Study
All participants completed the questionnaire. The results of the questionnaire are shown in Table 1 . The image quality and diagnostic performance of the HMZ-T2 were significantly superior (mean ± SD, 4.81 ± 0.40 and 4.50 ± 0.16, respectively) to the reference standard of the ultrasound machine-mounted monitor (average, 3), whereas those characteristics of the Wrap1200 (3.13 ± 0.50 and 3.19 ± 0.16) were nearly equal to the reference standard. No significant difference was observed in wearability or physical and visual fatigue between the HMZ-T2 and the Wrap1200. Neither motion sickness nor dizziness was observed when using either of the head-mounted displays. In the free question, there were 5 positive and 2 negative comments for the HMZ-T2 and 5 positive and 7 negative comments for the Wrap1200. Most of these comments were related to image quality and wearability. On the basis of these results, we decided to use the HMZ-T2 in the succeeding clinical study.
Clinical Study
Sonography using the HMZ-T2 was performed in 17 patients (mean age, 64.8 years; male/female, 14/3) by 5 examiners. Table 2 presents the clinical data for these examinations. Sonography revealed prostatic enlargement in 5 patients, renal cysts in 3, renal stones in 3, a bladder tumor in 1, and a renal mass in 1. As for the renal mass (case 1), subsequent magnetic resonance imaging confirmed that the mass was merely a portion of normal kidney tissue. The bladder tumor (case 8) was resected transurethrally afterward and found to be a urothelial carcinoma.
The results of the questionnaire are shown in Table 3 . All 17 participants completed the questionnaire. In clinical use, the HMZ-T2 had good image quality (4.12 ± 0.60), good diagnostic performance (3.82 ± 0.64), and good wearability (3.94 ± 0.56), without physical and visual fatigue (4.88 ± 0.12 and 4.82 ± 0.53, respectively). Motion sickness and dizziness were not observed in the clinical study. In the free question, there were 1 positive and 3 negative comments. The positive comment was related to image quality, whereas the negative comments included 1 problem concerning a limited direct visual field and 2 problems regarding wearability.
Takeshita 
Discussion
This study demonstrated the feasibility of commercially available modern head-mounted displays for sonographic examinations. In the preclinical study, both of the devices evaluated were applicable for sonography, with almost no unfavorable incidents for the examiners. Furthermore, we thought that the application of the goggle-type HMZ-T2 head-mounted display in clinical sonographic examinations was advantageous because of its excellent resolution and acceptable wearability. Additionally, this device is affordable and can be introduced into clinical practice easily and safely. Although the efficacies of head-mounted displays in medical practice need to be carefully evaluated, their usefulness is potentially high, and they may redefine sonographic examination and diagnostic procedures. The prevalence of musculoskeletal injury among sonographers is unexpectedly high and ranges from 63% to 99%. 10 Musculoskeletal injury is a severe problem that needs to be solved because as many as 20% of sonographers have reportedly had to end their careers due to injury. 8, 10 One of the causes of musculoskeletal injury is believed to be the posture adopted by the sonographer. 9, 10 In this study, we demonstrated the potential usefulness of head-mounted displays for reducing musculoskeletal injury by subjectively evaluating physical fatigue, which may be the first manifestation of injury. 8, 10 There are basically 2 different types of head-mounted display systems: see-through and non-see-through displays. See-through displays with adequate image quality are expected to be commercially available in the near future. 19 Nevertheless, we intentionally selected non-see-through displays for this procedure because we place great importance on image quality. As expected, the HMZ-T2 had high image quality and diagnostic ability, and it conferred a naturally ergonomic position to the examiner during scanning in both the preclinical and clinical studies.
In the clinical study, the evaluation of the diagnostic usefulness components for the HMZ-T2 scored about 0.7 points lower than in the preclinical study. This discrepancy was considered to have originated from the difference in the study designs. We evaluated the relative usefulness by comparing the head-mounted displays in the preclinical study, whereas in the clinical study, the absolute usefulness of the HMZ-T2 was evaluated, which might reflect the practical utility of this device for sonographic scanning.
Head-mounted displays have the potential not only to improve sonographic image quality and diagnosis but also to change conventional sonographic examination procedures. A head-mounted display in combination with a small portable ultrasound machine may allow examiners to perform high-quality sonographic examinations without reducing diagnostic performance everywhere, even outside the hospital in times of disaster. Moreover, by splitting the sonographic output into 2 head-mounted displays, the patient and the examiner can each wear a display so that they can share images simultaneously. This technique could contribute to a deeper self-understanding of the patient's health and accelerate patient-oriented personalized medicine.
Although our results suggest that modern headmounted displays are ready for clinical use in sonography, this study was not without limitations. First, although a comprehensive evaluation of abdominal organs usually needs about 15 to 20 minutes, only short-term (≈5 minutes) sonographic examinations of genitourinary tracts were performed in this study. Further evaluation would be needed to clarify the effect of applying head-mounted displays on the prevalence of musculoskeletal injury in long-term scanning. Second, one of the shortcomings of non-see-through head-mounted displays has been reported to be the difficulty in communicating with the patient because direct vision is limited by the device. 13 Nevertheless, because we could directly observe the patient by glancing downward below the device, wearing the HMZ-T2 was not found to hamper communication with the patient in this study. Our results suggest that the modern head-mounted displays are ready for clinical use in sonography, although they still have some wearability issues that need to be improved.
In conclusion, we have demonstrated that one of the modern high-definition head-mounted displays, the HMZ-T2, may be advantageous for sonographic scanning and diagnosis. This device is ready for clinical use and has the potential to change current sonographic procedures.
